Erik van den Berg: CEO of Memo Therapeutics

from BioBoss · host Erik van den Berg

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

Episode metadata supplied by the publisher feed · Published Oct 27, 2025

Embed this episode

Attribution link and audio player

Ready to play

Erik van den Berg: CEO of Memo Therapeutics

0:00 30:59

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 30 minutes long.

When was this BioBoss episode published?

This episode was published on October 27, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!